lead to progressive cardiomyocyte death. 6 The desmosomal mutations cause decreased function of sodium channels and gap junctions in cardiomyocytes. 6, 7 Exercise hastens disease progression by elevating myocardial wall stress, especially in the right ventricle (RV), 8 and has been linked to episodes of sudden cardiac death. Human and murine studies demonstrated that electrophysiological changes precede the structural disease. 9 Although originally described as an RV disease, there is increasing evidence for nonclassical presentation with both biventricular-and left ventricular (LV)-dominant disease. 10 Definitive diagnosis of ARVC requires histological demonstration of fibrofatty replacement of myocardium or the presence of a known ARVC genotype. Biopsy is challenging because the fibrofatty infiltration may be patchy and epicardial. Genotypes linked to ARVC are present in only 30% to 40% of cases. Current diagnosis uses a combination of structural, functional, and electrophysiological criteria. 3 However, diagnosis is challenging because of the progressive nature of ARVC and its early concealed phase. The only treatment proven to prevent sudden cardiac death in ARVC patients is the implantable cardioverter defibrillator. However, implantable cardioverter defibrillator implantation carries risks, and primary prevention indications remain a matter of debate. 4, 11 Effective noninvasive modalities and improved understanding of ARVC arrhythmia mechanisms are essential for accurate diagnosis and risk stratification. As stated in a recent editorial, access to the epicardium for electric measurements can enhance earlier disease detection. However, direct epicardial access is challenging and limited to experienced clinical centers. 12 The present study uses a noninvasive method (electrocardiographic imaging [ECGI] ; also referred to as electrocardiographic mapping or body-surface mapping) 13 for epicardial electrophysiology mapping and the latest generation of magnetic resonance imaging (MRI) for cardiac structure (cardiac MRI [CMR] with advanced late gadolinium enhancement [ LGE] using motion correction reconstruction). 14 We applied ECGI and LGE to study the electric and structural substrates in ARVC patients. These 2 techniques are safe, noninvasive, and well suited to longitudinal assessment of ARVC patients. The goal of this study is to provide insight into the myocardial substrate and arrhythmia mechanisms in ARVC. It also constitutes a preliminary exploration of the suitability of combined ECGI and LGE for diagnosis and risk stratification of ARVC patients.
Methods

Patient Cohort
Twenty ARVC patients with a broad spectrum of structural and electrophysiological disease were enrolled at the Heart Hospital, University College London Hospitals, London, United Kingdom. All patients were genotyped for desmosomal mutations. Patient characteristics are summarized in Table 1 (additional clinical characteristics provided in Tables II and III 
ECGI and MRI
The ECGI method was developed and validated in our laboratory as described previously. 13 A schematic of the procedure is presented in Figure I in the Data Supplement. Briefly, 256 uniformly distributed
WHAT IS KNOWN
• Arrhythmogenic right ventricular cardiomyopathy (ARVC) causes sudden death in the young.
• Diagnosis and risk stratification of ARVC patients are challenging, and the mechanisms of arrhythmia are incompletely understood.
WHAT THE STUDY ADDS
• Electrocardiographic imaging and magnetic resonance imaging-based late gadolinium enhancement reveal electrophysiological and structural abnormalities in ARVC patients.
• A novel mechanistic finding is that ventricular ectopy originates from regions with scar and prolonged repolarization.
• Application of electrocardiographic imaging and late gadolinium enhancement in combination is a promising strategy for diagnosis and risk stratification in ARVC. body-surface ECGs were recorded simultaneously using a portable recording system (ActiveTwo, BioSemi; The Netherlands). Patients exercised on a supine ergometer for 2 minutes, followed by a ramp protocol of 15 watts per minute to a maximum heart rate (HR) of 120 beats per minute. Recordings were performed in the supine position at rest, during exercise, and immediately after exercise cessation. ECGI data were transferred to the Rudy laboratory for data processing, map construction, and analysis.
Following the recording protocol, CMR was performed in a 1.5 T scanner (Magnetom Avanto, Siemens Medical Solutions, Germany). Before the scan, recording electrodes were replaced with MRI-visible markers so the electrode positions could be obtained in the same coordinate system as the heart geometry. A navigated anatomic sequence was used so the ECGI electric and anatomic data could be merged. Conventional cine imaging and advanced LGE imaging were conducted after the thorax scan. The contrast agent was 0.1 mmol/ kg of gadoterate meglumine (Dotarem; Guerbet SA, Paris, France) with LGE images acquired 5 to 15 minutes postcontrast. The LGE sequence was a single-shot, steady-state, free precession, phase-sensitive inversion recovery sequence 14 with motion corrected averaging and high resolution (typical matrix, 144×256; voxel size, 2.0×1.5×6.0 mm 3 ). Two patients declined contrast injection. Unipolar epicardial electrograms were reconstructed using previously described methods 13 (additional ECGI methodology references in the Data Supplement). Briefly, the heart-torso geometry obtained from the MRI was used to compute a transfer matrix relating epicardial potentials to torso potentials. The inverse problem was solved to compute epicardial electrograms from the recorded ECGs. Typically, 1000 electrograms were computed over the entire ventricular epicardium. Electrograms over the valve plane were excluded from analysis. Epicardial activation and repolarization maps were constructed from the electrograms. ECGI reconstructions of sinus rhythm were computed for each patient at resting HR before exercise and at elevated HR immediately after exercise cessation. Additionally, the epicardial activation sequence was computed for each unique premature ventricular contraction (PVC) morphology observed.
Analysis
Segmentation ECGI maps and LGE images for each patient's ventricles were divided into basal, mid, and apical regions. Basal and mid regions were further subdivided into anterior, anterolateral, inferolateral, and inferior regions. Apical regions were subdivided into anterior and inferior regions. Electrogram measures for each region were computed as the mean value from all electrograms within the region.
CMR Analysis
CMR analysis was performed using CVI42 software (version 5.1.2[303]; Circle Cardiovascular Imaging, Inc, Calgary, Canada). For the analysis of LGE in the LV, epicardial and endocardial borders were manually drawn on the short-axis slices, and the anterior RV insertion point was identified. The Otsu semiautomated technique was used to quantify LGE and was displayed on a bullseye plot as relative enhanced area (percentage) per segment on the 16-segment American Heart Association model.
For the analysis of the RV LGE, a segmentation model was created using short-axis images. Basal, mid, and apical segments were identified using the papillary muscles as markers and divided into anterior, anterolateral, inferolateral, and inferior segments for the basal and mid RV segments and as apical anterior and apical inferior segments for the RV apical segments.
The amount of RV LGE was quantified visually as 0 (no LGE), 1 (some LGE), or 2 (high LGE) independently by 2 operators with 3 years of experience in CMR each (Drs Rosmini and Bulluck). The operators' RV LGE quantification differed initially in 2 segments. After additional analysis of these segments, the reviewers reached a consensus. Analyses of the ECGI and CMR data were conducted independently with investigators blinded to the results of the other modality.
Electrogram Analysis
Reconstructed unipolar epicardial electrograms were processed to compute local electric measures. Activation times (ATs) were computed as the time of steepest negative time-derivative of voltage (−dV/ dt max ) in the local QRS complex. Recovery times (RTs) were computed as the time of steepest positive time-derivative (dV/dt max ) during the T wave. 15 Activation-recovery intervals (ARIs, a surrogate for local action potential duration) were computed as the difference between RT and AT. Figure II in the Data Supplement defines these measures. ECGI-reconstructed ARI values were validated against direct intraoperative epicardial mapping in humans (Zhang et al, 16 their online Data Supplement). Spatial gradient magnitudes of electrogram measures were computed for each electrogram as the absolute value of the change between neighboring electrograms divided by the distance between electrogram locations, averaged across all neighbors. Electrogram amplitudes were computed as the peak-to-peak voltage during the QRS complex. Fractionation was quantified using the number of steep downward deflections between QRS onset and the start of the T wave. Additional details of the fractionation quantification and sample electrograms are provided in Figure III in the Data Supplement. The earliest 10% of ATs were considered the epicardial initiation site of a PVC. PVC occurrence rates per electrogram at a given epicardial site were computed as the number of times the electrogram met the above criterion divided by the total number of beats recorded during the study.
Statistical Analysis
Fractionation values within anatomic segments are presented as Z scores compared with a group of 20 healthy adults. Electric measures in the ARVC study population were compared with healthy controls using Wilcoxon rank-sum tests. Exercise changes were assessed using Wilcoxon signed-rank tests. Cohort data are presented as medians and quartiles. Substrate and PVC rate comparisons were performed using Spearman correlation coefficients computed using MATLAB software (The MathWorks, Inc, Natick, MA).
Results
Electric Substrate at Rest
Abnormal sinus rhythm activation and conduction were common in the ARVC patients. The normal epicardial activation pattern is well described, 17 and a representative control is presented in Figure 1 . Generally, the earliest epicardial activation appears as a breakthrough, most commonly in the anterior RV, and the basal lateral LV is usually the latest region to activate ( Figure 1A ). The normal sinus activation of healthy adult hearts does not have regions of discontinuous conduction or fractionated electrograms ( Figure 1A and 1B; left). In contrast to the normal activation sequence, we observed abnormal and varied epicardial breakthrough locations, regions of discontinuous conduction, and fractionated electrograms in the ARVC study population.
Figures 2 through 4 present activation and conduction patterns seen in ARVC patients. In 2 patients with advanced disease (63 and 66 years old, respectively), we observed earliest epicardial breakthrough in the LV (Figures 2A and 3A) . One of these patients had normal epicardial electrograms (Figure 2A ), whereas we observed low-amplitude fractionated electrograms in the other ( Figure 3A ). ECGI resolved activation and conduction abnormalities in a 26-year-old patient who did not have any major task force diagnostic criteria. In this patient, we observed fractionated electrograms and nonuniform conduction near the earliest epicardial breakthrough site ( Figure 4A ). ARVC patients had fractionation scores within anatomic regions that ranged from values within the control range ( Figure 2B ; top) to values which were several SDs above the control distribution (Figures 3B and 4B ; top). Although some patients had high fractionation scores, we did not observe electrograms in these patients with deflections after the QRS complex (late potentials) that are commonly associated with re-entrant arrhythmias (Figures 2A through 4A) Repolarization in ARVC patients was prolonged compared with controls, and this prolongation was often spatially heterogeneous. Figure 1B we did not observe increased spatial gradients of repolarization or total duration of epicardial repolarization (Table IV in the Data Supplement).
The presence of T wave inversion on clinical ECG (clinical ECG findings in Table 2 in the Data Supplement) was strongly associated with ARI prolongation. ARVC patients with T wave inversion (Fridericia rate correction applied) had significantly longer mean ARI values than those without inversion (P=0.010; with inversion, 300 [269-313] ms; without inversion, 238 [231-262] ms). However, ECGI identified a patient without T wave inversion whose mean epicardial ARI was longer than any control, as well as a patient with T wave inversion whose mean epicardial ARI was within the lowest quartile of the control values (Table V in the Data Supplement).
Electric Substrate During Stress
As expected, mean epicardial ARI (uncorrected for HR) shortened because of exercise (P<0.001). Total RT (P=0.002), mean epicardial RT gradients (P=0.007), and mean electrogram amplitude (P<0.001) also decreased because of exercise. Total AT, mean epicardial AT gradients, and fractionation were unaffected by exercise (Table VI in the Data Supplement).
Structural (CMR) Substrate
Advanced LGE revealed a spectrum of scar burden in the ARVC patients. There was scar in 72% of ARVC patients agreeable to contrast. Three patients had isolated RV LGE, 7 had isolated LV LGE, 3 had biventricular LGE, and 5 had no scar. Six patients in the study cohort had no task force CMR defects. Of these 6, 3 had visible LV LGE. Panels B (bottom) and C of Figures 2 through 4 illustrate the broad spectrum of LGE observed in the study population.
Relationship of Electric and Structural Substrates
LGE scar spatially colocalized with electrophysiological substrate abnormalities, and the relationship between CMR scar and electrophysiological abnormalities was stronger in the LV than in the RV. The amount of LV LGE within anatomic segments correlated with electrogram markers of abnormal depolarization, including low-amplitude electrograms, increased number of deflections per electrogram, and increased AT spatial gradients. LV LGE correlated with prolonged resting ARI values and increase in ARI shortening during and postexercise (Table VII in The results from patient 6 ( Figure 2 ) and patient 14 ( Figure 3) illustrate the above findings. Patient 6 has an RV anatomic scar that does not extend to the epicardium, as determined from LGE ( Figure 2C ). The absence of scar on the epicardium is reflected in the local electrograms (electrogram 1; Figure 2A) , which seem normal. This is also reflected in the normal fractionation Z scores ( Figure 2B ; top). Patient 14 has a similar RV anatomic scar, which lacks clear epicardial involvement ( Figure 3C ). However, in this case, the ECGIreconstructed epicardial electrograms at this location (electrogram 1; Figure 3A ) are low amplitude and fractionated, indicating electrophysiological abnormality at the epicardium. The same patient also has an LV scar which is visible on the epicardial aspect of the lateral LV. For this scar, the corresponding epicardial electrograms (electrogram 2; Figure 3A) are fractionated, indicating coexistence of abnormal anatomic and electrophysiological substrates on the epicardium.
Ventricular Ectopy
Ventricular ectopy was common in the ARVC patients and occurred more frequently as HR increased after exercise. We observed PVCs in 15 of 20 ARVC patients, with a total of 41 distinct morphologies. The sites of earliest epicardial activation of the PVCs were spread across both ventricles, with greater involvement of RV and basal locations. A schematic diagram of the earliest epicardial activation sites for all PVC morphologies is provided in Figure 5 .
The PVC rate within anatomic segments correlated with prolonged ARIs, ARI shortening because of exercise, low voltage electrograms, increased deflections per electrogram, and LGE scar (all correlations P<0.001). The PVC rate within anatomic segments did not correlate with increased gradients in AT, RT, or ARI. Figures 6 and 7 show the temporal occurrence and spatial location and propagation of PVCs in 2 patients. The substrates for these patients are presented in Figures 2 and 3 
Discussion
This is the first evaluation of ECGI in ARVC patients. ECGI was sensitive enough to detect electrophysiological substrate differences between ARVC patients and healthy controls. By combining ECGI with LGE, we determined correlations between electrophysiological abnormalities and LGE scar. These correlations indicate that the electrophysiological abnormalities detected with ECGI are markers of disease progression. Importantly, new findings on properties of the electrophysiological and scar substrates included prolonged epicardial ARIs and a relationship of PVC rate within a region to repolarization, electrophysiological markers of scar, and LGE. 
ARVC Scar Substrate
Ventricular LGE was variable in location and extent. LV LGE was a more frequent finding than RV LGE. LV LGE colocalized with traditional markers of electrophysiological scar assessed using ECGI, as reflected by its correlation with lower voltage electrograms and increased fractionation. This finding mirrors prior ECGI studies that found regions of scar assessed with LGE or single-photon emission computed tomography to have lower voltage electrograms and increased fractionation. 18 In the RV, we did not observe a strong relationship between LGE and traditional electrophysiological markers of scar. This is consistent with prior work comparing invasive electrophysiology mapping to RV LGE, which found that ≈50% of electric scar substrates in the RV were not confirmed by LGE. 19 Prior studies have suggested that the absence of RV LGE findings could be attributed to the thin RV wall, which complicates LGE in the RV. 20 Alternatively, it is possible that electrophysiological abnormalities in the RV manifest in the presence of minimal scar or scar that is diffuse and not easily resolved with current imaging techniques.
Prolongation of Repolarization
There are multiple mechanisms which could contribute to the ARI prolongation observed in this study. Functional changes in ionic currents because of ARVC mutations could contribute to prolonged repolarization. Studies linking I Na current to Plakophilin-2 mutations provided the first evidence that ARVC may have some features of a channelopathy. 21 Although the focus of research efforts in this area has largely been on depolarization, it is possible that repolarizing currents are altered as well. K v 1.5 channels localize to the intercalated disc and associate with Na v 1.5, 22, 23 and K v 1.5 function depends on N-cadherin, an intercalated disc protein. 24 A mutation in KCNE2 that inhibits trafficking of K v 1.5 to the intercalated disc causes prolonged repolarization. 25 Although we are unaware of direct evidence suggesting that this mechanism is involved in ARVC, it is an interesting avenue for exploration.
Another mechanism which may contribute to prolonged repolarization is progression of the heart failure phenotype associated with ARVC. Heart failure is a known end-stage complication of ARVC, 4 but systolic impairment of varying degrees can appear in either or both ventricles in the absence of clinical heart failure. 10 Action potential prolongation is a hallmark of heart failure along with functional downregulation of potassium currents, slow conduction, and abnormal calcium homeostasis. 26 It is possible that these features develop in ARVC patients either globally or locally as the disease progresses, and surviving myocardium is subjected to increasing strains because of fibrofatty tissue replacement.
Finally, myocardial uncoupling can increase the effects of any action potential duration prolongation mechanisms. Myocardial uncoupling facilitates gradients in repolarization by decreasing the electrotonic coupling between cells. 27 Fibrofatty replacement acts to uncouple cells by decreasing the local density of excitable cells. Reduction in the number and size of gap junctions in the intercalated disc causes further uncoupling in ARVC and has been reported even in histologically normal regions of myocardium. 6 In our data, ARI prolongation correlated with LGE in both ventricles. This suggests that the uncoupling effect of the scar, altered mechanical strains in regions of scar, or both may be important to the development of prolonged repolarization. The uncoupling effect of ventricular scar could also contribute to the correlation we observed between stress-related ARI shortening and LGE in both ventricles, because both rate increase and sympathetic stimulation have a greater effect on cardiomyocytes that are less electrically coupled. Although our population size is not sufficient to draw conclusions about the age progression of the ARVC phenotype, we note that the group included 2 patients in their twenties, both of whom had ARI values within the normal range. This suggests that action potential prolongation in ARVC patients may develop as the overall phenotype progresses. Mean epicardial ARIs were generally longer in patients with precordial lead T wave inversion. However, there were patients with and without T wave inversion who were exceptions to this relationship, indicating that ECGI offers improved sensitivity and specificity for detecting prolonged repolarization. Additionally, ECGI provides spatial information about ARI prolongation, which was spatially heterogeneous in ARVC.
Arrhythmia Triggers (PVCs)
The ability of ECGI to panoramically map the whole heart in a single beat allowed us to localize PVCs, determine the frequency of each unique PVC morphology, and correlate ectopic frequency with the electrophysiological and scar substrates. The overall rate of PVCs was increased by exercise. We found that PVC rate within anatomic segments correlated with local ARI prolongation, increased ARI shortening because of exercise, low voltage electrograms, fractionated electrograms, and LGE.
The hallmark finding of progressive scar formation in ARVC is compatible with the possibility of re-entrant circuit formation. Prior work demonstrated conduction slowing at elevated HRs in ARVC patients. 28 In the present study, we found evidence of slow conduction in the form of longer total ATs and steeper activation gradients relative to controls. However, we did not observe the dynamic conduction slowing at elevated HRs that Finlay et al 28 reported. This discrepancy could be attributable to the difference in HRs investigated. In the present study, patients exercised to a peak HR of 120 beats per minute, whereas the patients in the Finlay et al study were paced at an interval just below the ventricular refractory period. The combination of scar, slow conduction, and prolonged repolarization could facilitate unidirectional block and reentrant arrhythmia. Important signatures of re-entrant arrhythmia are electrogram fractionation and late potentials. We did not observe late potentials in the reconstructed electrograms. This stands in contrast to ECGI studies of postinfarction scarrelated ventricular tachycardia, which found a high prevalence of late potentials with re-entry circuits closely related to the electrophysiological substrate. 29 Although this could indicate that re-entrant arrhythmias are less prevalent in ARVC, it is important to note the significant differences in the anatomy of the scars in each population. Postinfarction scars are often large and heterogeneous, with large islands of surviving myocardium, especially in the border zone. The ARVC scar substrate, on the other contrary, accumulates gradually over time and is typically diffuse, originating from the epicardium. It is possible that the lower regional density of surviving myocardium in ARVC scar makes it difficult to resolve late potentials in electrophysiology mapping of ARVC patients.
Focal mechanisms may cause arrhythmia triggers in ARVC patients. Focal triggered activity is commonly observed in isolated myocytes in the form of early afterdepolarizations or delayed afterdepolarizations. Early afterdepolarizations at plateau potentials are caused by recovery and reactivation of I Ca , with the delayed rectifier currents, I Kr and I Ks , playing an important role. 30 We observed that PVC rate correlated with regions of prolonged ARI-a surrogate for local action potential duration-including during stress when I Ca is augmented by β-adrenergic stimulation. Action potential duration prolongation increases the window for I Ca reactivation and early afterdepolarization formation. In the intact heart, electrotonic coupling between myocytes acts as a current sink for depolarizing currents. Reduced coupling, caused by scar and gap junction abnormalities in ARVC, can increase the likelihood of focal activity by decreasing the current sink effect. The observed correlation between PVC rate and electric and LGE markers of scar suggests that an uncoupling effect is present at PVC initiation sites. It is interesting to note that Myles et A, Time-course of observed PVCs in relation to exercise and schematic map of PVC initiation sites. The different PVC initiation sites are labeled A, B, and C and color coded. PVCs occurred only after the onset of exercise, and morphology C appeared only once near peak heart rate (HR). B, Activation isochrone maps of the 3 distinct PVC morphologies observed in this patient. Asterisks indicate PVC initiation sites. Morphology B showed a broad region of early epicardial activation, indicating a possible subepicardial origin and possible conduction system involvement. AT indicates activation time; bpm, beats per minute; LA, left atrium; LV, left ventricle; RA, right atrium; and RV, right ventricle. Electrophyisologic and Structural Substrate of ARVC al 31 found that focal activity was more common in the RV, which they attributed to reduced coupling in the thin RV wall compared with the LV. In our study, we found greater overall ectopy in the RV.
Clinical Implications
The progressive nature of ARVC and its early concealed phase complicate diagnosis and treatment. CMR currently plays a valuable role in the evaluation of ventricular structure and function. The current task force criteria do not include LGE but acknowledge that it may be included in future revisions. 3 Our data show that combined ECGI and LGE could increase the sensitivity for detecting substrate abnormalities in ARVC patients, including young patients with little or no task force MRI and ECG criteria. LGE and ECGI are compatible with the current use of CMR in the diagnosis and longitudinal assessment of ARVC. These imaging techniques can be performed in addition to the conventional CMR assessment to provide a thorough characterization of structural, functional, and electrophysiological abnormalities. In the present study, we report a spectrum of abnormalities using these techniques and demonstrate a relationship between the imaged substrates and ventricular ectopy. Because ventricular ectopy may play a causal role in triggering arrhythmias, combined ECGI and LGE may have a role in risk stratification.
Limitations
This study is a first evaluation of combined ECGI and LGE in ARVC patients and, therefore, evaluated a relatively small group of 20 patients. Because CMR is commonly contraindicated in patients with implanted devices, we only recruited patients without implantable cardioverter defibrillators. Although this choice enabled us to image LGE in the study cohort, a drawback is that none of the patients in this study had prior episodes of ventricular tachycardia. Therefore, this study cohort is not well suited for evaluating sudden cardiac death risk stratification. Further studies are necessary to explore this application of these techniques. The current study evaluated patients ranging in age from 24 to 75 years old; however, only 3 patients were <41 years of age. Future studies should evaluate whether this approach can detect the presence of ARVC in young, asymptomatic, and genotypepositive individuals. Larger studies of a wide range of ages and genotypes are important for exploring the progression of the disease, including how the electrophysiological and scar substrates change over time. Prior studies demonstrated that strain imaging may be effective for detecting the early stages of ARVC and for risk stratification. 32, 33 Future studies could combine ECGI and strain imaging into a multimodality approach for ARVC diagnosis and risk stratification. Exercise and LGE data were collected from the ARVC patients but not controls. These data are needed to establish ranges for healthy controls. Additional data are necessary to determine the specificity of ECGI and LGE criteria for diagnosis of ARVC.
Conclusion
ECGI in combination with advanced LGE reveals a spectrum of electric and structural substrate abnormalities in ARVC patients. This combination may improve sensitivity for detecting ARVC substrate abnormalities. These data suggest a role for combined ECGI and LGE in early diagnosis, noninvasive follow-up, and risk stratification of ARVC patients.
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